APA (7th ed.) Citation

KB, B., CK, L., AK, S., MB, V., HBW, L., E, R., . . . B, G. (2025). Cerebral glutamate levels over two years in initially antipsychotic-naïve first-episode patients with psychosis are related to clinical symptoms and cognition. Molecular psychiatry, 30(12), 5652. https://doi.org/10.1038/s41380-025-03234-3

Chicago Style (17th ed.) Citation

KB, Bojesen, Lemvigh CK, Sigvard AK, Vestergaard MB, Larsson HBW, Rostrup E, Ebdrup BH, and Glenthøj B. "Cerebral Glutamate Levels over Two Years in Initially Antipsychotic-naïve First-episode Patients with Psychosis Are Related to Clinical Symptoms and Cognition." Molecular Psychiatry 30, no. 12 (2025): 5652. https://doi.org/10.1038/s41380-025-03234-3.

MLA (9th ed.) Citation

KB, Bojesen, et al. "Cerebral Glutamate Levels over Two Years in Initially Antipsychotic-naïve First-episode Patients with Psychosis Are Related to Clinical Symptoms and Cognition." Molecular Psychiatry, vol. 30, no. 12, 2025, p. 5652, https://doi.org/10.1038/s41380-025-03234-3.